ALDR - Alder BioPharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts13131515
Avg. Estimate-0.94-0.94-4.45-3.18
Low Estimate-1.37-1.38-5.76-5.23
High Estimate-0.68-0.66-3.55-1.45
Year Ago EPS-1.04-0.91-4.87-4.45
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts11111315
Avg. EstimateN/AN/AN/A77.03M
Low EstimateN/AN/AN/A30k
High EstimateN/AN/AN/A195M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-1.05-1.09-0.94-1.03
EPS Actual-1.04-0.91-1.19-1.63
Difference0.010.18-0.25-0.6
Surprise %1.00%16.50%-26.60%-58.30%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.94-0.94-4.45-3.18
7 Days Ago-0.94-0.94-4.45-3.18
30 Days Ago-0.94-0.94-4.45-3.18
60 Days Ago-0.98-0.99-4.46-3.24
90 Days Ago-1.09-1.12-4.36-3.21
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesALDRIndustrySectorS&P 500
Current Qtr.9.60%N/AN/A0.01
Next Qtr.-3.30%N/AN/A0.03
Current Year8.60%N/AN/A0.04
Next Year28.50%N/AN/A0.10
Next 5 Years (per annum)23.46%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A